Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer
Choline C 11 Injection is administered intravenously to produce an image that helps to locate specific body sites for follow-up tissue sampling and testing in men with recurrent prostate cancer
SRP is the most effective treatments for locally recurrent prostate cancer
after initial radiation therapy.
Now, Life Extension Clinical Research is supporting a clinical trial examining the use of vitamin D in treating slow-growing recurrent prostate cancer
BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed European oncologists are most concerned about the risk of myocardial infarction/stroke associated with long-term hormonal treatment for biochemically recurrent prostate cancer
patients, but it is a rare adverse event.
HIFU as salvage first-line treatment for palpable, TRUSevidenced, biopsy-proven locally recurrent prostate cancer
after radical prostatectomy: A pilot study.
Professor Damian Greene, Consultant Urologist at Sunderland Royal Hospital in the UK, considers cryotherapy an extremely valuable option in the treatment of primary as well as recurrent prostate cancer
The virus was tested in 20 patients who had locally recurrent prostate cancer
following radiotherapy or brachytherapy, said Dr.
11 Focal Salvage Cryoablation in Recurrent Prostate Cancer
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer
after radical prostatectomy.
Damian Greene, Consultant Urologist at Sunderland Royal Hospital in the UK, considers cryotherapy a valuable option in the treatment of primary and recurrent prostate cancer
This proposal is a natural extension of this work and will focus specifically on men with advanced and recurrent prostate cancer
and whether diet and lifestyle factors can reduce risk of distant metastasis or prostate cancer-specific mortality.
Food and Drug Administration (FDA) has tentatively scheduled a Gastroenterology and Urology Devices Advisory Committee Panel meeting on October 2, 2014 to review the Company's Premarket Approval (PMA) application for Sonablate 450 for the treatment of recurrent prostate cancer
following external beam radiation treatment (EBRT) in the U.
An FDA approved safety trial for locally recurrent prostate cancer
is already enrolling patients in the US.
Two additional studies support the favorable claims made in recent medical literature about the use of PET scans to evaluate patients with recurrent prostate cancer